nach oben

International Urogynecology Journal

Erschienen in:

01.04.2012 | IUGA Grafts Roundtable 2010

Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse

Consensus of the 2nd IUGA Grafts Roundtable: Optimizing Safety and Appropriateness of Graft Use in Transvaginal Pelvic Reconstructive Surgery

verfasst von: Dennis Miller, Alfredo L. Milani, Suzette E. Sutherland, Bonnie Navin, Rebecca G. Rogers

Erschienen in: International Urogynecology Journal | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Complex issues surround informed surgical consent for pelvic reconstructive surgery.

Methods

Vaginally placed mesh/grafts are used with the intent to increase durability of the repair but potentially introduce unique complications, offering new challenges in informed surgical consent counseling.

Results

Informed consent is a process that takes place throughout the entire consultation with the patient. A written document often accompanies that process. This paper outlines necessary components of informed surgical consent and the theory behind each component.

Conclusions

We explore elements that should be included in the consent process with regard to expected benefits, alternatives, and material risks that are specific to the use of a mesh/graft-augmented vaginal repair of prolapse. Included is an appendix that may serve as a template for the creation of a surgeon’s own written informed consent document.

Nur mit Berechtigung zugänglich

Del Carmen MG, Joffe S (2005) Informed consent for medical treatment and research: a review. Oncologist 10:636–641PubMedCrossRef

ACOG Committee on Ethics (2006) Innovative practice: ethical guidelines. ACOG Committee Opinion Number 352. Obstet Gynecol 108:1589–1595

Schenker Y, Meisel A (2011) Informed consent in clinical care: practical considerations in the effort to achieve ethical goals. JAMA 305(11):1130–1131PubMedCrossRef

Beauchamp TL, Childress JF (2001) Principles of biomedical ethics. Oxford University Press, Oxford

Berg JW, Applaud PS, Lidz CW et al (2001) Informed consent: legal theory and clinical practice. Oxford University Press, Oxford

Abed H, Rogers R, Helitzer D, Warner TD (2007) Informed consent in gynecologic surgery. Am J Obstet Gynecol 197(6):674.e1–5

Field AD (2004) Informed consent: not just for procedures anymore. Am J Gastroenterol 99:977–980

Meisel A, Roth LH, Lidz CW (1997) Toward a model of the legal doctrine of informed consent. Am J Psychiatry 134:285–289

American Medical Association (2007) Removing barriers to better, safer care. Health literacy and patient safety: help patients understand. Reducing the risk by designing a safer shame-free health environment. Patient monograph. American Medical Association, Chicago

10.

Fink AS, Prochazka AV, Henderson WG et al (2010) Enhancement of surgical informed consent by addition of repeat back: a multicenter, randomized controlled clinical trial. Ann Surg 252(1):27–36PubMedCrossRef

11.

Heit M, Culligan P, Rosenquist C, Shott S (2002) Is pelvic organ prolapse a cause of pelvic low back pain? Obstet Gynecol 99:23–28PubMedCrossRef

12.

Slieker-ten Hove MC, Pool-Goudzwaard AL, Eijkemans MJ et al (2009) The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population. Int Urogynecol J Pelvic Floor Dysfunct 20:1037–1045PubMedCrossRef

13.

De Boer TA, Kluivers KB, Withagen MI, Milani AL, Vierhout ME (2010) Predictive actors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J Pelvic Floor Dysfunct 21(9):1143–1149CrossRef

14.

(2008) Interventional Guidance 267. National Institute for Health and Clinical Excellence (NICE), London

15.

Nguyen JN, Burchette RJ (2008) Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 111(4):891–898PubMedCrossRef

16.

Nieminen K, Hiltunen R, Heiskanen E, Takala T, Niemi K, Merikari M, Heinonen PK (2008) Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J 19:1611–1616CrossRef

17.

Sivaslioglu AA, Unlubilgin E, Dolen I (2008) A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J 19:467–471CrossRef

18.

Miller D, Lucente V, Babin E et al (2011) Prospective clinical assessment of the transvaginal mesh technique for treatment of pelvic organ prolapse 5-year results. Female Pelvic Med Reconstr Surg 17:139–143CrossRef

19.

Caquant F, Collinet P, Debodinance P et al (2008) Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res 34(4):449–456PubMedCrossRef

20.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRef

21.

Maher C, Baessler K, Glazener EJ, Adams HS (2008) Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn 27:3–12PubMedCrossRef

22.

Hagen S, Stark D, Glazener C, Sinclair L, Ramsay I (2009) A randomized controlled trial of pelvic floor muscle training for stages I and II pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 20:45–51PubMed

23.

Dumouulin C, Hay-Smith J (2008) Pelvic floor muscle training versus no treatment for urinary incontinence in women. A Cochrane systematic review. Eur J Phys Rehabil Med 44:47–63

24.

Cundiff GW, Amundsen CL, Bent AE et al (2007) The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol 196:404.e1–404.e8

25.

Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9(5):485–493PubMedCrossRef

26.

Schenfeld N (2003) Informed consent and its changing nature. Skin Aging 11(07)

27.

US Food and Drug Administration (2008) FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/UCM061976

28.

Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG (2011) Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. doi:10.1007/s00192-011-1384-5

29.

Kobashi KC, Govier FE (2003) Management of vaginal erosion of polypropylene mesh slings. J Urol 169(6):2242–2243PubMedCrossRef

30.

Jacquetin B, Cosson M (2009) Complications of vaginal mesh: our experience. Int Urogynecol J 20:893–896CrossRef

31.

Araco F, Gravante G, Sorge R, Overton J, De Vita D, Primicerio M, Dati S, Araco P, Piccione E (2009) The influence of BMI, smoking, and age of vaginal erosions after synthetic mesh repair of pelvic organ prolapses. A multicenter study. Acta Obstet et Gynecol 88:772–780CrossRef

32.

Withagen MI, Viehout ME, Hendricks JC, Kluivers KB, Milani AL (2011) Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol 118:629–636PubMedCrossRef

33.

Achtari C, Hiscock R, O’Reily BA, Schierlitz L, Dwyer PL (2005) Risk factors for mesh erosion after transvaginal surgery using polypropylene (Atrium) or composite polypropylene/polyglactin 910 (Vypro II) mesh. Int Urogynaecol J Pelvic Dysfunct 16:389–394CrossRef

34.

Nazemi TM, Kobashi KC (2007) Complications of grafts used in female pelvic floor reconstruction: mesh erosion and extrusion. Indian J Urol 23(2):153–160PubMedCrossRef

35.

Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW et al (2011) An international Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classifications of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Int Urogynecol J 22:3–15PubMedCrossRef

36.

US Food and Drug Administration (2009) Information on surgical mesh for pelvic organ prolapse and stress urinary incontinence. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm142636.htm

37.

Lowenstein L, FitzGerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER, Brubaker L (2008) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J 19(1):81–84CrossRef

Titel: Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse
Consensus of the 2nd IUGA Grafts Roundtable: Optimizing Safety and Appropriateness of Graft Use in Transvaginal Pelvic Reconstructive Surgery
verfasst von: Dennis Miller
Alfredo L. Milani
Suzette E. Sutherland
Bonnie Navin
Rebecca G. Rogers
Publikationsdatum: 01.04.2012
Verlag: Springer-Verlag
Erschienen in: International Urogynecology Journal / Ausgabe Sonderheft 1/2012
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-012-1680-8

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Informed surgical consent for a mesh/graft-augmented vaginal repair of pelvic organ prolapse

Consensus of the 2nd IUGA Grafts Roundtable: Optimizing Safety and Appropriateness of Graft Use in Transvaginal Pelvic Reconstructive Surgery